BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10373828)

  • 21. Updated management of non-st-segment elevation acute coronary syndromes: selection of patients for low-cost care: an analysis of outcome and cost effectiveness.
    Conti A; Pieralli F; Sammicheli L; Camaiti A; Vanni S; Grifoni S; Dovellini E; Antoniucci D; Squillantini G; Mazzuoli F; Colombo G
    Med Sci Monit; 2005 Mar; 11(3):CR100-8. PubMed ID: 15735561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical redesign using all patient refined diagnosis related groups.
    Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
    Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using activity-based costing to track resource use in group practices.
    Zeller TL; Siegel G; Kaciuba G; Lau AH
    Healthc Financ Manage; 1999 Sep; 53(9):46-50. PubMed ID: 11066706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemolytic uremic syndrome (HUS): medical and social costs of treatment].
    Caletti MG; Petetta D; Jaitt M; Casaliba S; Gimenez A
    Medicina (B Aires); 2006; 66 Suppl 3():22-6. PubMed ID: 17354473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A national disease registry moves beyond clinical impact, fostering measurable cost savings at the community hospital level.
    Finlay A; Cosovich C; Gebur S
    J Health Care Finance; 2000; 27(2):8-29. PubMed ID: 11140552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
    Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
    Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculating pass-through and outlier payments under APCs.
    Gold M; Snodgrass S
    Healthc Financ Manage; 2001 Jul; 55(7):54-7. PubMed ID: 11467231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are your outlier charges likely to raise CMS scrutiny?
    Davino M
    Healthc Financ Manage; 2004 Feb; 58(2):40-4. PubMed ID: 14997717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The balancing act: patient care time versus cost.
    Storfjell JL; Omoike O; Ohlson S
    J Nurs Adm; 2008 May; 38(5):244-9. PubMed ID: 18469618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives?
    Dimick JB; Pronovost PJ; Cowan JA; Lipsett PA
    J Am Coll Surg; 2003 May; 196(5):671-8. PubMed ID: 12742194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation in critical care medicine.
    Cox HL; Laupland KB; Manns BJ
    J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost containment in critical care.
    Laphan L
    Am J Crit Care; 1996 Jul; 5(4):319. PubMed ID: 8811159
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rationing in surgery and high-tech medicine].
    Stulz P
    Praxis (Bern 1994); 2000 Nov; 89(45):1857-61. PubMed ID: 11109923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a Canadian community hospital.
    Marshall JK; Collins SM; Gafni A
    Am J Gastroenterol; 1999 Jul; 94(7):1841-6. PubMed ID: 10406245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F; Egger R; Bauerfeind P; Beglinger C
    Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using databases for studying and comparing health care costs and resource use.
    Melfi CA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):399-402. PubMed ID: 11802584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationing and critical care medicine.
    Ward NS; Levy MM
    Crit Care Med; 2007 Feb; 35(2 Suppl):S102-5. PubMed ID: 17242597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of technology on costs and patient outcome.
    Ahrens T
    Crit Care Nurs Clin North Am; 1998 Mar; 10(1):117-25. PubMed ID: 9644353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.